4M Therapeutics
PrivateLast Round
Seed
Aug 28, 2025
Total Funding Raised
$4.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
4M Therapeutics is a biotechnology company that develops targeted therapies for neuropsychiatric and neurodegenerative conditions using a proprietary human brain cell platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4M Therapeutics Comparables
Compare 4M Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cogentis Therapeutics | 89% | |
| AMO Pharma | 80% | |
| Autobahn Therapeutics | 76% |
4M Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 28, 2025 | ||||
| Grant | Nov 12, 2024 | ||||
| Pre Seed | Aug 28, 2023 |
4M Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LvlUp Ventures | Pre Seed |
| Harvard Alumni Entrepreneurs | Pre Seed |
| SynGAP Research Fund | Grant, Pre Seed |
| Endless Frontier Labs | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 36% MoM.
- Jan 21, 2026
Monthly visitors grew 126% MoM, reaching 2.9K.
4M Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 4M Therapeutics's valuation, stock price, and market status.
Is 4M Therapeutics a public or private company?
4M Therapeutics is a private company.
What is the current stock price of 4M Therapeutics?
4M Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is 4M Therapeutics worth (valuation)?
Valuation information for 4M Therapeutics is not publicly available.
Can I buy 4M Therapeutics stock?
4M Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 4M Therapeutics's last funding round?
4M Therapeutics's most recent funding round was Seed on August 28, 2025.
Who are the main investors in 4M Therapeutics?
Key investors in 4M Therapeutics include LvlUp Ventures, Harvard Alumni Entrepreneurs, SynGAP Research Fund, Endless Frontier Labs.
Will 4M Therapeutics IPO soon?
No public IPO plans have been announced for 4M Therapeutics.
How can I track 4M Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4M Therapeutics's secondary market activity and sign up for updates.